LYMPHOCYTE SENESCENCE IN COPD IS ASSOCIATED WITH DECREASED HISTONE DEACETYLASE 2 EXPRESSION BY PRO-INFLAMMATORY LYMPHOCYTES by Hodge, G. et al.
PUBLISHED VERSION  
http://hdl.handle.net/2440/96813  
 
Greg Hodge, Hubertus Jersmann, Hai B. Tran, Eugene Roscioli, Mark Holmes, Paul N. Reynolds and 
Sandra Hodge 
Lymphocyte senescence in COPD is associated with decreased histone deacetylase 2 expression by 
pro-inflammatory lymphocytes 
Respiratory Research, 2015; 16(1):130-1-130-11 
© 2015 Hodge et al. Open AccessThis article is distributed under the terms of the Creative Commons 
Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits 
unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit 
to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver 
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this 
article, unless otherwise stated. 





























Hodge et al. Respiratory Research  (2015) 16:130 
DOI 10.1186/s12931-015-0287-2RESEARCH Open AccessLymphocyte senescence in COPD is
associated with decreased histone deacetylase
2 expression by pro-inflammatory lymphocytes
Greg Hodge1,2*, Hubertus Jersmann1,2, Hai B. Tran1, Eugene Roscioli1, Mark Holmes1,2, Paul N. Reynolds1,2
and Sandra Hodge1,2Abstract
Background: Histone acetyltransferases (HAT) and histone deacetylases (HDAC) are enzymes that upregulate and
down-regulate pro-inflammatory gene transcription respectively. HDAC2 is required by corticosteroids to switch off
activated inflammatory genes and is reduced in lung macrophages in COPD. We have shown that COPD patients
have increased steroid resistant CD28null (senescent) pro-inflammatory T and NKT-like peripheral blood cells
(particularly CD8+ subsets) and we hypothesized that these changes would be associated with a loss of HDAC2
from these senescent pro-inflammatory lymphocytes.
Methods: Blood was collected from 10 COPD and 10 aged-matched controls. Intracellular pro-inflammatory
cytokines, IFNγ and TNFα, and expression of CD28, HDAC2 and HAT, were determined in lymphocyte subsets
in the presence of ± 5 mg/ml theophylline (HDAC2 activator), 10 μM prednisolone and 2.5 ng/ml cyclosporine A
(immunosuppressant), using flow cytometry.
Results: There was a loss of HDAC2 from CD28null CD8+ T and NKT-like cells in COPD. There was a significant negative
correlation between HDAC2 expression and the percentage of CD28null CD8+ T and NKT-like cells producing IFNγ or
TNFα in all subjects (eg, COPD: R = −.763, p < 0.001 for T-cell IFNγ). There was a synergistic upregulation of HDAC2 and
associated decrease in pro-inflammatory cytokine production in CD28nullCD8+ T and NKT-like cells in the presence of
5 mg/L theophylline + 10−6 M prednisolone or 2.5 ng/mL cyclosporine A (CsA).
Conclusions: Lymphocyte senescence in COPD is associated with loss of HDAC2 in CD28nullCD8+ T and NKT-like cells.
Alternative treatment options such as combined theophylline with low-dose CsA, that inhibit these pro-inflammatory
cells, may reduce systemic inflammation in COPD.
Keywords: Lymphocyte senescence, COPD, HDAC2, CD28nullCD8+ T and NKT-like cells, IFNγ and TNFαBackground
Chronic obstructive pulmonary disease (COPD) is a lead-
ing cause of death world wide and existing treatments,
such as anti-inflammatory corticosteroids, have no proven
disease modifying effect [1]. The mechanisms underlying
this resistance are largely unknown, particularly in lym-
phocytes [2]. We have reported increased production of
pro-inflammatory cytokines and expression of cytotoxic* Correspondence: greg.hodge@health.sa.gov.au
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CD8+ T cells in the peripheral blood and lungs [3] of
current and ex-smoker COPD patients compared to
healthy smokers and never-smokers [4].
Our research has focused on identifying the lymphocyte
subset/s resistant to current therapeutics and we have
made several important discoveries. We have shown that
COPD is associated with increased CD28nullCD8+ senes-
cent cells in the peripheral blood of both current and ex-
smoker COPD subjects, and showed these cells are more
cytotoxic/pro-inflammatory than CD8 +CD28+ cells [5].
It has been shown that smoking enhances telomere short-
ening and senescence in circulating lymphocytes whichis distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Table 1 Demographic details of the COPD and control group.
Subjects Controls COPD
No. of subjects 10 10
Age (years) 49 (±8) 58 (±16)*
FEV1, % pred 108.4 (±9) 60.1 (±20)*
FEV1, % FVC 96 (±12) 58 (±15)*
Male/Female 8/6 6/4
Data showing mean ± SEM
FEV1 forced expiratory volume in 1 second, FVC forced vital capacity,
*P < 0.05 compared to controls
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showed NKT-like and NK cells were increased in bron-
choalveolar lavage (BAL) of COPD patients, associated
with increased cytotoxicity by both cell types [7]. CD8 +
CD28null NKT-like cells have been shown to be more
pro-inflammatory and cytotoxic than CD8 +CD28+ NKT-
like cells in other pro-inflammatory lung diseases [8].
Our research identified increased levels of drug efflux
pump, Pgp-1 in peripheral blood cytotoxic/pro-inflam-
matory T and NKT-like lymphocyte subsets [9] although
there were no changes between CD28null and CD28+
subsets suggesting other causes were responsible for
conferring steroid resistance in these lymphocyte sub-
sets. In this regard, we recently we showed these
CD28nullCD8+ T-cells have reduced levels of gluco-
corticoid receptor (GCR) [10]. While this may help
explain their resistance to steroid treatment, there
may be other factors involved.
Histone acetyltransferases (HAT) and histone deacety-
lases (HDAC) are enzymes that up-regulate and down-
regulate pro-inflammatory gene transcription respectively
[11]. HDAC2 is required by corticosteroids to switch off
activated inflammatory genes and has been shown to be
reduced in lung macrophages in COPD [11].
We hypothesized that levels of HDAC2 may also be
decreased in peripheral blood CD28nullCD8+ T and
NKT-like lymphocyte subsets in patients with COPD
and conversely, levels of HAT may be increased in these
subsets.
To investigate this hypothesis, we determined whether
peripheral blood CD28null T cells (particularly CD8+)
and NKT-like cells from COPD patients express reduced
levels of HDAC2 and/or increased HAT and whether
loss of HDAC2 (and/or increased HAT) is associated
with increased expression of cytotoxic mediators or pro-
inflammatory cytokines. Low dose theophylline has been
reported to increase levels of HDAC2 in lung macro-
phages and reduce inflammatory gene expression [12].
We therefore also investigated the effect of theophylline
and immunosuppressant, cylclosporin A (CsA) (which
we had previously shown reduced levels of Pgp-1 [9]) in
combination with the corticosteroid, prednisolone, on
HDAC2 and associated pro-inflammatory cytokine ex-
pression by lymphocyte subsets.
Methods
Patient and control groups
COPD volunteers were specifically recruited for the study
and informed consent obtained. There was no exacerba-
tion of COPD for 6 weeks prior. Subjects with other co-
existing lung disease or malignancy or aged greater than
75y were excluded. Ethics approval was obtained from the
Royal Adelaide Hospital and the experiments were
conducted with the understanding and the writtenconsent of each participant. COPD was diagnosed using
the GOLD criteria with clinical correlation (mild COPD:
FEV1/FVC < 70 % but FEV1 ≥ 80 % predicted; moderate
COPD FEV1 50 % ≤ 80 % predicted, severe COPD FEV1
30 % ≤ 50 % predicted, very severe COPD FEV1 < 30 %)
[13]. Blood was collected from 10 patients with COPD
(Table 1) all of whom were ex-smokers (at least one year)
with an average of 37 pack years. No patients were receiv-
ing oral GCS.
Blood was also obtained from 10 aged-matched non-
smoking volunteers (Table 1) with normal lung function.
These were healthy, recruited volunteers with no history
of airways disease. All subjects underwent spirometry as
part of their routine clinical assessment. Venous blood
was collected into 10 U/mL preservative free sodium hep-
arin (DBL, Sydney, Australia), and maintained at 4 °C until
processing. All patients were submitted to the same proto-
col and analysis performed retrospectively.
HDAC2, HAT, granzyme b and perforin expression in T
and NKT-like cell subsets
Histone acetyltransferases (HAT) and histone deacetylases
(HDAC) are enzymes that up-regulate and down-regulate
pro-inflammatory gene transcription respectively [11]. We
have previously shown peripheral blood T and NKT-like
cells express increased cytotoxic mediators perforin and
granzyme b with increased cytotoxic function (4,7) but it
is unknown which subsets express the greatest potential
cytoxicity to lung epithelial cells [14]. To determine ex-
pression of HDAC2, HAT, and cytotoxic mediators
granzyme b and peforin in CD8+ and CD8- T and
NKT-like cells, aliquots of blood were added to FACS
tubes and red blood cells were lysed using FACSLyse
(BD Biosciences, Sydney, Australia) as described previ-
ously [4]. After 10 min, tubes were centrifuged at 300 × g
for 5 min and leucocytes permeabilised using FACSPerm
(BD) as previously reported [4]. Cells were then washed
with wash buffer (0.5 % BSA in Isoflow (Beckman Coulter,
Sydney, Australia)). After centrifuging and decanting
supernatant, 5 μL of appropriately diluted anti- HDAC2
(clone Y461, Merck Millipore, Sydney, Australia) or acety-
lated lysine antibody (Cell Signaling Technology, Sapphire
Bioscience, Sydney, Australia) was added for 15 min in the
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and 5 uL appropriately diluted goat anti rabbit IgG1 PE
(Invitrogen, Sydney, Australia) was added for 15 min. Fol-
lowing washing of cells, appropriately diluted monoclonal
antibodies to perforin FITC (eBiosciences, Sydney,
Australia), CD3 perCP.CY5.5 (BD), CD28 PECY7 (BD),
CD56 APC (Beckman Coulter, Sydney, Australia), CD8
APC.CY7 (BD), granzyme B V450 (BD) and CD45 V500
(BD) were added for 15 min in the dark at RT. After wash-
ing cells in wash buffer, centrifugation and decanting, cells
were analyzed within 1 h on a FACSCanto II flow cyt-
ometer using FACSDiva software (BD). Samples were ana-
lyzed by gating lymphocytes using CD45 staining versus
side scatter (SSC). A minimum of 350,000 low SSC events
were acquired in list-mode format for analysis. T cells
were identified as CD3 +CD56-CD45+ and NKT-like cells
identified as CD3 +CD56+ CD45+ low FSC/SSC events
[7].
HDAC2, HAT and intracellular cytokine expression in T
and NKT-like cell subsets
To determine expression of HDAC2 and HAT with
intracellular cytokine production in CD8+ and CD8- T
and NKT-like cells, aliquots of blood were stimulated as
previously reported [3] with phorbol myristate acetate
(25 ng/mL) (Sigma, Sydney, Australia) and ionomycin
(1 μg/mL) (Sigma) in the presence of brefeldin A (1 μg/Ml)
(Sigma) and the tubes incubated in a humidified 5 % CO2/
95 % air atmosphere at 37 °C. Preliminary experiments
showed the addition of brefeldin A had no effect on
HDAC2 or HAT expression in these experiments. At 16 h
100 μL 20 mM EDTA/PBS was added to the culture tubes
which were vortexed vigorously for 20 sec to remove ad-
herent cells. Red blood cells were lysed and cells were
permeabilized as described previously [3]. Two mL 0.5 %
bovine serum albumin (Sigma/Aldrich, Sydney, Australia)/
Isoflow (Beckman Coulter, Sydney, Australia) was then
added and the tubes centrifuged at 300 × g for 5 min. After
decanting supernatant, Fc receptors were blocked with
10 μL human immunoglobulin (Intragam: CSL, Parkville,
Australia) for 10 min in the dark at RT. Cells were stained
with anti-HDAC2 or acetylated lysine monoclonal anti-
body as described above. Following washing of cells, ap-
propriately diluted monoclonal antibodies to IFNγ FITC,
CD3 perCP.CY5.5 (BD, Sydney, Australia), CD28 PECY7
(BD), CD56 APC (Beckman Coulter, Sydney, Australia),
CD8 APC.CY7 (BD), TNFα V450 (BD) and CD45 V500
(BD) were added for 15 min in the dark at room
temperature. Two mL of wash buffer was then added and
the tubes centrifuged at 300 × g for 5 min. After decant-
ing, cells were analyzed within 1 h on a FACSCanto II flow
cytometer using FACSDiva software (BD). Samples were
analyzed by gating lymphocytes using CD45 staining ver-
sus side scatter (SSC). A minimum of 350,000 low SSCevents were acquired in list-mode format for analysis. T
cells were identified as CD3 + CD45+ and NKT-like cells
identified as CD3 + CD56+ CD45+ low FSC/SSC events.
Effect of drugs on HDAC2, HAT and intracellular IFNγ
expression in T and NKT-like cell subsets
Our aim was to determine the effect of methylpredniso-
lone (10−6M) with a selective activator of HDAC2, theo-
phylline (5 mg/L) [11] on HDAC2 expression and
production of IFNγ and TNFα by CD8+ and CD8− T and
NKT-like cells. Cyclosporin A is a Pgp-1 inhibitor and we
have previously shown that pro-inflammatory cytokine
production was significantly reduced in T and NKT-like
cells in the presence of very low dose cyclosporine A
(2.5 ng/mL) [9]. The effect of HDAC inhibitor, trichostatin
A (10 ng/ml) on HDAC2 expression and IFNγ and TNFα
by CD8+ and CD8− T and NKT-like cells was also investi-
gated. To determine the effect of these drugs on HDAC2
expression in pro-inflammatory T and NKT-like cells, ali-
quots of blood were mixed in 10 mL sterile tubes with
equal volume of RPMI 10 % FCS and incubated with
drugs (and combinations) and the tubes incubated in a
humidified 5 % CO2/95 % air atmosphere at 37 °C for
24 h. Blood cultures were then stimulated as for intracel-
lular cytokine production as described above for 16 h. Ali-
quots of blood cultures were then processed as for
intracellular cytokines and HDAC2, HAT, IFNγ and TNFα
expression as described above.
HDAC2 expression in CD28+ and CD28null T cells by
Western Blot
PBMC were isolated from blood of a cohort of control and
COPD patients by standard density gradient centrifugation
and cells re-suspended at 1x107 mL in RPMI 1640 medium.
Following stimulation as described above, 5 μL of appropri-
ately diluted CD3 perCP.CY5.5 (BD), CD28 PE.CY7 (BD),
CD56 APC (Beckman Coulter), CD8 APC.CY7 (BD) and
CD45 V500 (BD) monoclonal antibodies were added for
15 min in the dark at room temperature. Cells were
washed and resuspended in 1 mL RPMI and CD28+ and
CD28null, CD8+ and CD8− T cells were immediately
sorted on a FACSAria flow cytometer (BD).
Equal numbers of sorted CD28+ and CD28 null T cells
were lysed using M-Per mammalian cell protein lysis
reagent with Halt® protease inhibitor cocktail (both
Thermo Scientific, Victoria, Australia). Protein samples
were quantified using the DC protein assay (Bio-Rad,
Victoria, Australia), and 10 μg electrophoresed using
Novex® 4–12 % gradient Bis-Tris denaturing gels (Life
Technologies, Victoria, Australia) and electroblotted to
Trans-Blot® Turbo nitrocellulose membrane (Bio-Rad).
Membranes were blocked in 5 % diploma skim milk ,
washed, then incubated overnight at 4 °C with anti-human
HDAC2 (1:2000), followed by a 1 h incubation at RT with
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antibody (R&D Systems, MN, USA). Chemiluminescent
imaging was performed using the LAS-3000 platform, and
histogram analysis performed using the Multigauge soft-
ware package (both FugiFilm, Tokyo, Japan). Mouse-anti
Human β-actin antibody (Sigma-Aldrich, MO, USA) was
used to correct for loading error for histogram analyses.
HDAC2 expression in CD28+ and CD28null T cells by
Fluorescent Microscopy
1x103 sorted CD28+ and CD28 null T cells (as described
above) were added to a Cytospin 4 cytocentrifuge (Ther-
moFisher Scientific, Scorseby, Victoria, Australia) and
centrifuged for 500 g for 5 min. Slides were air dried for
10 min and cells fixed with 2.5 % formalin in PBS for
10 min. Cytospins were treated with 1 % sodium dodecyl
sulphate (SDS, Sigma Aldrich, Castle Hill, NSW, Australia)
in PBS for 5 min, followed by 1 h incubation with a serum-
free protein blocker (Dako A/S, Glostrup, Denmark), over-
night incubation at 4 °C with 1/25 diluted HDAC rabbit
monoclonal antibody (Serotec, Abacus ALS, Brisbane,
Australia), then 1 hour with AF594-conjugated donkey IgG
F(ab’)2 fragment polyclonal antibody to rabbit IgG (Abcam,
Sapphire Bioscience, Waterloo, NSW, Australia), and
counterstained with DAPI (Sigma-Aldrich). Cells were
washed between incubation with 0.01 M Tris-buffered
saline pH 7.5, containing 0.05 % Tween-20. Immunofluor-
escence was detected and imaged with a Olympus IX73
fluorescence microscope (Olympus, Notting Hill, VIC,
Australia). For quantitative analysis, cells from each cytos-
pin were photographed under a 40x objective in 8 optical
fields, selected in the DAPI channel for bias prevention,
the mean fluorescence intensities measured then in the
AF594 channel using the ImageJ software (NIH, Bethesda,
MD, USA) as previously described [15].
Statistical Analysis
Statistical analysis was performed using the Wilcoxon
sign rank test. For T-cell subsets CD28null/CD8+/
CD3+/CD56−/CD45+/TNFα+/IFNγ+), a sample size
of n = 10 allowed a power of 98–99.5 % for analysis.
Variance was estimated from our previous studies [3–5, 7].
Correlations were performed using Spearman Rho correl-
ation tests. SPSS software was applied and differences be-
tween groups of p < 0.05 considered significant.
Results
Increased CD28null CD8+ T and NKT-like cells in COPD
patients
There was a significant increase in CD28nullCD8+ T cells
in patients with COPD compared with healthy controls,
but no change in CD28nullCD8− T cells (CD28nullCD8+
T: 57 ± 8.4 (33 ± 8.5); CD28nullCD8− T: 7.1 ± 3.1 (5.9 ± 4.2)
for COPD patients (controls) (median ± SEM) consistentwith our previous findings for CD28null T cells [5]. There
was a significant increase in CD28nullCD8+ NKT-like
cells in patients with COPD compared with healthy
controls but no change in CD28nullCD8− NKT-like
cells (CD28nullCD8+ NKT-like: 39 ± 5.9 (22 ± 6.1);
CD28nullCD8− T: 8.8 ± 3.6 (7.8 ± 3.3) for COPD pa-
tients (controls).
HDAC2 and HAT expression by CD28+ and CD28null T
and NKT-like cells
A significantly lower percentage of CD28nullCD8+ T
and NKT-like cells expressing HDAC2 in both COPD
groups and controls was found, compared with CD28+
T and NKT-like cells (Data for T cell and NKT-like cell
subsets from COPD group shown in Fig. 1) (data for
controls not shown). There was no change in the
percentage of CD28nullCD8+ or CD8− T or NKT-like
cells expressing HAT in COPD patients compared with
control or compared with CD28+ T and NKT-like cells
(data not shown).
Granzyme b and perforin expression by CD28+ and
CD28null T and NKT-like cells
These experiments were performed to determine which
subsets expressed the highest cytotoxic potential (14).
There was a higher percentage of CD28nullCD8+ T cell
and NKT-cells expressing perforin and granzyme b in
COPD patients compared with control subjects (eg., 45 ±
13 (14 ± 12) p = .037; and 33 ± 13 (12 ± 8) p = .025 for the
percentage of CD28null CD8+ T cells expressing gran-
zyme b and perforin (median ± sd) from COPD patients
(controls). There was no change in perforin or granzyme
b expression in CD28 + CD8+ or CD8− T and NKT-like
cells from COPD or control groups (p > 0.05 for all).
There was a correlation between HAT expression in
CD28nullCD8+ T and NKT-like cells co-expressing per-
forin and granzyme b in the COPD group but not con-
trols (eg., R = .071, P = .031 for HAT + granzyme b +
CD28nullCD8+ T cells for COPD group).HAT, HDAC2 and IFNγ and TNFα production by CD28+
and CD28null T and NKT-like cells
A significant increase in the percentage of CD28nullCD8
+ T and NKT-like cells producing IFNγ and TNFα com-
pared with CD28 + CD8+ T and NKT-like cells was
noted in COPD patients and control groups (data for
CD28null and CD28+ CD8+ and CD8− T and NKT-like
cells producing IFNγ for the COPD group shown in
Fig. 2) (data for IFNγ and TNFα production for the con-
trol group and TNFα production by the COPD group
not shown). There was no correlation between HDAC2 or
HAT expression and the percentage of pro-inflammatory
cytokine producing T cells or NKT-like cells in COPD or
Fig. 1 The percentage of CD28+ and CD28null (CD28-) CD8+ and CD8- T cells (clear bars) and NKT-like cells (grey bars) in patients with COPD.
Data presented as box plots. There was a significant decrease in the percentage of CD28nullCD8+ T and NKT-like cells expressing HDAC2
compared with CD28+CD8- and CD28+CD8+ Tand NKT-like cells
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tive correlation between loss of HDAC2 expression by
CD28nullCD8+ T cells and the percentage of these
cells producing IFNγ (Fig. 3) and TNFα (data not
shown) in the COPD group but not the controlFig. 2 The percentage of CD28+ and CD28null (CD28-) CD8+ and CD8- T
patients with COPD. Data presented as box plots. There was a significant d
expressing IFNγ compared with CD28+CD8- and CD28+CD8+ T and NKT-ligroup. There was a negative correlation between loss
of HDAC2 expression by CD28nullCD8+ NKT-like
cells and the percentage of these cells producing IFNγ
(R = −.647, P = .039) and TNFα (R = −.557, P = .043)
in the COPD group.cells (clear bars) and NKT-like cells (grey bars) producing IFNγ in
ecrease in the percentage of CD28nullCD8+ T and NKT-like cells
ke cells
Fig. 3 There was a significant negative correlation between the
percentage of CD28nullCD8+ T cells expressing HDAC2 and
producing IFNγ in COPD subjects
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CD28nullCD8+ T and NKT-like cells co-expressing
IFNγ (Fig. 4a). and TNFα.(not shown). A representative
dot plot showing an increased percentage of HAT+
CD28nullCD8 + T cells co-expressing IFNγ + in a COPD
patient compared with HAT + CD28 + CD8+ T cells is
shown in Fig. 4b.
HDAC2 expression in CD28+ and CD28null T cells by
Fluorescent Microscopy
Sorted CD28+ and CD28null T cells were stained for
HDAC2 expression. There was significant positive staining
with HDAC2 in CD28+ T cells compared with CD28null
T cells using fluorescence microscopy (Fig. 5b). HDAC2
staining was mainly located in the CD28+ T cell nucleus
(Fig. 5a).
HDAC2 expression of CD28+ and CD28null T cells by
Western Blot
Equal numbers of FACS-sorted CD28+ and CD28null T
cells were stained for HDAC2 expression by Western
Blot. There was a decrease in the 55kD band corre-
sponding to the HDAC2 in CD28null T cells compared
with CD28+ T cells (Fig. 5c). HDAC2 expression relative
to β-actin from CD28 null (CD28−) and CD28+ T cells
(mean ± sem from 3 experiments) is shown in Fig. 5d.
Correlation between HDAC2 by CD28nullCD8+ T cells and
FEV1
There was a correlation between HDAC2 expression by
CD28nullCD8+ T cells and FEV1 from the COPD group
(Fig. 6) but no correlation between HDAC2 expression
by any other lymphocyte subset with FEV1 (% predicted)
(data not shown).Effect of drugs on HDAC2 and intracellular cytokine
expression by CD28null CD8+ T and NKT-like cells in
COPD patients
The effect of 5 mg/ml theophylline (Th) ± 10−6 M meth-
ylprednisolone (MP) or 2.5 ng/ml CsA, on the upregula-
tion of HDAC2 (Fig. 7a) and inhibition of IFNγ
production by CD28nullCD8+ T cells (Fig. 7b) is shown
in Fig. 7. There was no effect on HDAC2 or IFNγ in the
presence of theophylline alone. There was significant
increase in the percentage of CD28nullCD8+ T cells
expressing HDAC2 in the presence of MP, CsA or a
combination of both. There was a synergistic increase in
the percentage of CD28nullCD8+ T cells expressing
HDAC2 in the presence of theophylline, and MP or CsA
or combination. Similar results were obtained for upreg-
ulation of HDAC2 and inhibition of IFNγ production by
CD28 + CD8+ and CD8− T cells and CD28+ and
CD28nullCD8+ and CD8− NKT-like cells (ie., results
were similar for all T and NKT-like subsets). The pres-
ence of the HDAC inhibitor, trichostatin A (10 ng/ml),
negated 80 ± 15 % (median ± SEM) of the inhibitory
effect of theophylline and MP on IFNγ and TNFα by
CD8+ and CD8− T and NKT-like cells. Representative
dot plots showing the combined effect of 5 mg/ml theo-
phylline and 2.5 ng/ml CsA on the percentage of
CD28nullCD8+ T and NKT-like cells expressing HDAC2
and IFNγ is shown in Fig. 7c.
Discussion
This is the first study to show that lymphocyte senescence
in associated with loss of HDAC2 from CD8 + CD28null
T and NKT-like cells. The loss of HDAC2 was shown to
correlate with the cytotoxic/pro-inflammatory potential of
these cells and importantly, disease severity in patients
with COPD. HDAC2 is required by corticosteroids to
switch off activated inflammatory genes [11]. We have
recently shown a loss of glucocorticoid receptor (GCR)
expression by these lymphocyte subsets [10]. Taken to-
gether with our current data, these findings suggest that
multiple factors may be influencing steroid resistance in
these cells. Interestingly, a previous study showed loss of
HDAC2 by alveolar macrophages from patients with
COPD without a reduction in GCR nuclear translocation
[16]. In contrast, we showed similar rates of nuclear trans-
location of GCR in both CD28null and CD28+ T and
NKT-like lymphocyte subsets, suggesting that the reduced
levels of HDAC2 do not hinder GCR nuclear translocation
by these cells [10]. Senescent CD28null T and NKT-like
cells have been shown to be more pro-inflammatory and
cytotoxic than their CD28 positive counterparts [5, 10],
and exhibit a relative resistance to corticosteroids [10].
Increased pro-inflammatory CD8+ T cells in peripheral
blood and lungs [3] and an increase in cytotoxic NKT-like























































































Fig. 4 a There was a significant correlation between the percentage of CD28nullCD8+ T cells co-expressing HAT.IFNγ and IFNγ. b A representative dot
plot showing an increased percentage of HAT+ CD28nullCD8+ T cells co-expressing IFNγ + (23 %) in a COPD patient compared with HAT + CD28+
CD8+ T cells (9 %)
Hodge et al. Respiratory Research  (2015) 16:130 Page 7 of 11patients compared to healthy and never-smokers [7]. We
have also identified increased CD28nullCD8+ cells in both
current and ex-smoker COPD groups [5].
HDAC2 activity has been shown to be reduced in the
lung parenchyma, bronchial biopsies, alveolar macro-
phages and peripheral blood monocytes of patients with
COPD [17–19]. However, there have not been any stud-
ies identifying changes in HDAC2 in lymphocytes, par-
ticularly cytotoxic/pro-inflammatory subsets from these
patients, although there has been a study that identified
a reduction in total HDAC activity in PBMCs from
smokers who had COPD [18]. This study showed a rela-
tionship between smoking pack-years, loss of total
HDAC activity and increased serum IL-8 levels in
smokers with COPD. The authors suggested this loss of
total HDAC was due to a decrease in monocyte HDAC.
Our findings suggest this may have been due in part toloss of HDAC2 in CD28nullCD8+ lymphocyte subsets
rather than monocytes alone. In this regard our current
study showed a negative correlation between the percent-
age of CD28nullCD8+ T and NKT-like cells producing
pro-inflammatory cytokines IFNγ and TNFα and the per-
centage expressing HDAC2. Although the HDAC2 has
been shown to be the relevant isoform for enhancement
of steroid responsiveness in alveolar macrophages, meas-
urement of HDAC1 may have proven interesting in our
current study although a recent report suggests HDAC1
to be more important for maintaining CD4+ T cell lineage
integrity [20] rather than CD8+ T cells.
A previous study showed no change in HAT levels in
lung macrophages in patients with COPD [19] consist-
ent with our current findings for T and NKT-like cells.
However, we did find a correlation between the percent-
age of HAT + CD8+ T and NKT-like cells co-expressing
AB
Fig. 5 a Representative laser confocal images of HDAC2 staining (red) in FACS-sorted CD28null (right) and CD28+ T cells (left). Blue was DAPI
counterstaining. Scale bar = 8um. The bar graph depicts results of quantitative analysis by ImageJ. Experiments were repeated 3 times, showing
similar results. *** p < 0.05. b Representative Western Blot of equal numbers of sorted CD28+ and CD28null T cells, stained for HDAC2 expression.
There was a decrease in the 55kD band corresponding to the HDAC2 in CD28null T cells compared with CD28+ T cells. Bar graph showing
HDAC2 expression relative to β-actin from CD28 null (CD28-) and CD28+ T cells (mean ± sem from 3 experiments)
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inflammatory cytokines, IFNγ and TNFα suggesting an
increase in acetylation of histones in cells upregulating
these pro-inflammatory cytokines with a corresponding
decrease in HDAC2.
There has been a previous suggestion of an age-related
or senescent-specific HDAC associated with histone H4




















Fig. 6 Correlation between HDAC2 expression by CD28nullCD8+ T
cells with FEV1 (% predicted) in COPD subjectsacetylation of our lymphocyte subsets may prove en-
lightening in this regard. HDAC activity in peripheral
blood monocytes has been reported to correlate with
smoker pack years in COPD patients [18]. Another
important addition to our studies would be to determine
whether HDAC2 levels in lymphocyte subsets are altered
in smokers who have not progressed to COPD and
whether there is any correlation with smoking pack
years in smokers and COPD patients.
Importantly we now show these HDAC2 deficient
lymphocytes are present in the systemic circulation of
COPD patients. Barnes et al. proposed a spillover of cells
from the lungs into the systemic circulation [2], which
suggest these HDAC2 deficient cells may have originated
in the lung.
Interestingly, our present study showed that a loss
of HDAC2 expression by CD28nullCD8+ T and
NKT-like cells was also observed in healthy control
subjects, although at decreased numbers compared
with patients with COPD ie., HDAC2 expression was
the same in CD28null T and NKT-like cells from
both subject groups. Lymphocyte senescence and GC
resistance have been described in several other in-
flammatory conditions, such as cardiovascular dis-
ease [22], autoimmune disease [23], arthritis [24],
IBD [25], aging [26] and aging with associated in-
flammation in COPD [27]. One could speculate that
AC
B
Fig. 7 a Graphs showing the effect of 5 mg/ml theophylline (Th) ± 10−6 M prednisolone (MP) or 2.5 ng/mL cyclosporine A (CsA) or combination
on the upregulation of HDAC2 (a) and inhibition of IFNγ production by CD28nullCD8+ T cells is shown in (b). There was no effect on HDAC2 or
IFNγ in the presence of theophylline alone. There was significant increase in the percentage of CD28nullCD8 + T cells expressing HDAC2 in the
presence of MP, CsA or combination (p < 0.05 for all). There was a synergistic increase in the percentage of CD28nullCD8 + T cells expressing
HDAC2 in the presence of theophylline and MP or CsA or a combination. c Representative dot plots showing the combined effect of 5 mg/mL
theophylline (Theo) and 2.5 ng/mL cyclosporine A (CsA) on the percentage of CD28null CD8+ T (top plots) and NKT-like cells (bottom plots)
expressing HDAC2 and producing IFNγ. Note the significant increase in HDAC2 and significant decrease in IFNγ in both CD28null subsets in the
presence of theophylline and cyclosporine A
Hodge et al. Respiratory Research  (2015) 16:130 Page 9 of 11these cells may be the precursors to other inflammatory
diseases. Our findings suggest that the relative GC resist-
ance of the CD28null inflammatory lymphocytes need tobe considered with any therapeutic approaches, and alter-
native therapies to GC may be required to avoid suscepti-
bility to inflammatory diseases.
Hodge et al. Respiratory Research  (2015) 16:130 Page 10 of 11A previous study showed treatment with low dose theo-
phylline upregulated total HDAC in peripheral blood
monocytes and increased FEV1% predicted when com-
bined with inhaled fluticasone propionate in patients with
COPD compared with theophylline alone [28] consistent
with our current findings where theophylline alone had no
effect on HDAC2 but combined with prednisolone and/or
very low dose cyclosporine A resulted in synergistic
upregulation of HDAC2 and subsequent sensitivity to
prednisolone. Furthermore, our results indicate treatment
with low dose CsA with theophylline alone may increase
HDAC2 and reduce inflammation and help overcome the
reported adverse effects of steroids in COPD [29].
We have previously shown cytotoxic/pro-inflammatory
T and NKT-like cells have increased levels of drug efflux
pump, Pgp-1, and the presence of very low dose CsA, a
Pgp-1 inhibitor, resulted in steroid sensitivity of these
cells [9]. Taken together with our current findings this
suggests that combined treatment with very low dose
CsA, standard dose prednisolone and theophylline may
be a drug combination of choice to target cytotoxic/pro-
inflammatory lymphocytes in patients with COPD. Our
ex vivo assays to study HDAC2/GCR deficient lympho-
cytes may identify COPD patients that would benefit
from these combination of drugs. Further lymphocyte
phenotyping post therapy could identify effectiveness of
this therapy.
Conclusion
In conclusion, lymphocyte senescence in COPD is associ-
ated with loss of HDAC2 in CD28nullCD8+ T and NKT-
like cells. This loss is related to disease severity in COPD,
thus therapies aimed at increasing HDAC2 expression in
pro-inflammatory senescent lymphocytes are warranted.
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